Patents by Inventor Lynne Weaver

Lynne Weaver has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-CD11D antibodies and uses thereof
    Patent number: 11873340
    Abstract: Antibodies to human CD11d, compositions comprising such CD11d antibodies, and methods of using such CD11d antibodies for the treatment of central nervous system trauma including spinal cord injury and traumatic brain injury, as well as systemic inflammatory response following central nervous system trauma.
    Type: Grant
    Filed: February 24, 2017
    Date of Patent: January 16, 2024
    Assignees: The University of Western Ontario, Eli Lilly and Company
    Inventors: Gregory Dekaban, Arthur Brown, Lynne Weaver, Allan Barrett, Kristine Kikly
  • ANTI-CD11D ANTIBODIES AND USES THEREOF
    Publication number: 20230183355
    Abstract: Antibodies to human CD11d, compositions comprising such CD11d antibodies, and methods of using such CD11d antibodies for the treatment of central nervous system trauma including spinal cord injury and traumatic brain injury, as well as systemic inflammatory response following central nervous system trauma.
    Type: Application
    Filed: February 24, 2017
    Publication date: June 15, 2023
    Inventors: Gregory DEKABAN, Arthur BROWN, Lynne WEAVER, ALLAN Barrett, Kristine KIKLY
  • Methods of treating chronic pain using compositions that specifically bind cd11d (alpha-d) integrin
    Publication number: 20070092515
    Abstract: Methods to treat secondary injury resulting from spinal cord injury using polypeptide compositions that specifically bind to CD11d are disclosed.
    Type: Application
    Filed: November 8, 2004
    Publication date: April 26, 2007
    Applicant: Icos Corporation
    Inventors: Lynne Weaver, Gregory Dekaban, Mark Oatway